Back to today’s briefing

Story perspectives

Onapgo Revolutionizes Parkinson's Treatment with 85% Success Rate

4/14/2025

49 12

Summary

Story summary

Onapgo has emerged as a groundbreaking treatment for advanced Parkinson's disease, showing remarkable results in reducing off time and boosting good on time for patients. In the Phase 3 INFUS-ON trial, over 85% of participants experienced significant improvements over three years, with the treatment proving to be safe and well-tolerated.

1 of 1

Story summary

Onapgo has emerged as a groundbreaking treatment for advanced Parkinson's disease, showing remarkable results in reducing off time and boosting good on time for patients. In the Phase 3 INFUS-ON trial, over 85% of participants experienced significant improvements over three years, with the treatment proving to be safe and well-tolerated.